(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering.
The report provides insights into Bayer AG's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Bayer AG (Bayer) is a German life sciences company engaged in the research, development, manufacture, and supply of healthcare and Agriculture products. It is the parent company of the Bayer Group and performs the key management functions for the whole enterprise. The Bayer Group has three business divisions: Crop Science, Pharmaceuticals, and Consumer Health. Pharmaceuticals is engaged in manufacturing prescription medicines, particularly for cardiology and women's healthcare.
It also produces specialty therapeutics for ophthalmology, hematology, oncology, and cell and gene therapy. The division also has a radiology business which markets diagnostic imaging equipment and digital solutions. Consumer Health manufactures over-the-counter (OTC) medicines, nutritional supplements, medicated skincare products, and self-care solutions for pain, allergy, cough, and digestive health. Meanwhile, Crop Science offers seeds, improved plant traits, biological and chemical crop protection products, and digital farming solutions.
The report provides information and insights into Bayer's tech activities, including:
Insights of its digital transformation strategies and innovation programs. Overview of technology initiatives covering partnerships and product launches. Insights on each technology initiative including technology theme, objective, and benefits. Details of estimated ICT budgets and major ICT contracts.
Reasons to Buy
Gain insights into Bayer's tech operations. Gain insights into its tech strategies and innovation initiatives. Gain insights into its technology themes under focus. Gain insights into various product launches and partnerships.
Key Topics Covered:
Overview Digital Transformation Strategy Accelerators, Incubators, and Innovation Programs Technology Focus Technology Initiatives Venture Arm Investments Acquisitions Partnership, Investment & Acquisition Network Map ICT Budget Key Executives
A selection of companies mentioned in this report includes, but is not limited to:
AWS Capgemini Google Microsoft Huma Gandeeva Therapeutics GRO Biosciences Luxsonic Technologies NextRNA Therapeutics VeChain Pilloxa
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
MENAFN20012025004107003653ID1109107932
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.